Neo Ivy Capital Management Abb Vie Inc. Transaction History

Neo Ivy Capital Management

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$132.51 - $164.9 $118,463 - $147,420	894 New	894 $120,000
Q3 2022 Nov 15, 2022	BUY	$134.21 - $153.93 $157,562 - $180,713	1,174 New	1,174 $158,000
Q2 2022 Aug 16, 2022	SELL	$137.62 - $174.96 $75,140 - $95,528	-546 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $72,061 - $89,407	546 New	546 $88,000
Q3 2021 Nov 16, 2021	SELL	$106.4 - $120.78 $236,420 - $268,373	-2,222 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $155,710 - $173,470	-1,480 Reduced 39.98%	2,222 $250,000
Q1 2021 Oct 07, 2021	BUY	$102.3 - $112.62 $378,714 - $416,919	3,702 New	3,702 $401,000
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $363,331 - $490,536	-4,514 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$85.91 - $100.83 $111,683 - $131,079	1,300 Added 40.45%	4,514 $395,000
Q2 2020 Aug 17, 2020	SELL	$73.37 - $98.18 $2,861 - $3,829	-39 Reduced 1.2%	3,214 $315,000
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $27,154 - $41,169	-421 Reduced 11.46%	3,253 $248,000
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $265,005 - $331,578	3,674 New	3,674 $325,000
Q3 2019 Nov 21, 2019	SELL	$62.98 - $75.72 $202,417 - $243,364	-3,214 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$65.7 - $83.98 $470,083 - $600,876	-7,155 Reduced 69.0%	3,214 $234,000
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $799,864 - $941,401	10,369 New	10,369 $835,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.